Provectus Biopharmaceuticals Inc

OTC: PVCT    
Share price (4/26/24): $0.20    
Market cap (4/26/24): $83.3 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.4
from 10-Q 9 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D-1 Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series D-1 Convertible Preferred Stock of Provectus Biopharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page State of Delaware Certificate of Elimination of Certificate of Designation of Series B Convertible Preferred Stock of Provectus Biopharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 10 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D-1 Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 10 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 10-K 3 pages State of Delaware Certificate of Incorporation a Stock Corporation
12/34/56
EX-3.2
from 8-K 3 pages Provectus Biopharmaceuticals, Inc. First Amendment to the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 14 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series C Convertible Preferred Stock
12/34/56
EX-3.3
from S-1/A 14 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series C Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 15 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series B Convertible Preferred Stock
12/34/56
EX-3.1
from 10-Q 3 pages State of Delaware Certificate of Incorporation a Stock Corporation
12/34/56
EX-3.2
from 10-K 1 page Certificate of Amendment to the Certificate of Incorporation of Provectus Biopharmaceuticals, Inc
12/34/56
EX-3.4
from 10-K 19 pages Corporate Seal
12/34/56
EX-3.3
from 10-K 25 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation (Pursuant to Section 151 of the General Corporation Law of the State of Delaware) Series a 8% Convertible Preferred Stock Par Value $.001 Per Share
12/34/56
EX-3.2
from 10-K 17 pages Provectus Biopharmaceuticals, Inc. Certificate of Designation (Pursuant to Section 151 of the General Corporation Law of the State of Delaware) 8% Convertible Preferred Stock Par Value $.001 Per Share
12/34/56
EX-3.1
from 10-K 4 pages Certificate of Incorporation State of Delaware Certificate of Incorporation a Stock Corporation
12/34/56
EX-3.1
from 8-K 25 pages Provectus Pharmaceuticals, Inc. Certificate of Designation (Pursuant to Nrs 78.1955) Series a 8% Convertible Preferred Stock Par Value $.001 Per Share
12/34/56
EX-3.1
from S-3 ~1 page Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 17 pages Provectus Pharmaceuticals, Inc. Certificate of Designation (Pursuant to Nrs 78.1955) 8% Convertible Preferred Stock Par Value $.001 Per Share
12/34/56
EX-3.1
from 8-K ~5 pages Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporation
12/34/56